LQDA Q3 2024 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+20.9% YoY

Gross Profit

$3M64.8% margin

Operating Income

-$29M-656.2% margin

Net Income

-$23M-520.6% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+21.6%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$27M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$253M

Total Liabilities

$142M

Stockholders' Equity

$111M

Cash & Equivalents

$204M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+20.9%
Gross Profit	$3M	$3M	-7.2%
Operating Income	-$29M	-$15M	-96.0%
Net Income	-$23M	-$16M	-46.6%